Analyst Ratings for Allergen (AGN)
AGN Rating Summary
AGN Price Target Summary
- Highest: $135.00 (JMP Securities)
- Lowest: $89.00 (Piper Jaffray)
- Average: $107.47
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$107.47 (+9.6%)
Avg. $ Target:
$107.47 (+9.6%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/10/2013 | BMO Capital | New Coverage | Outperform (N/A) |
118.00 (N/A) |
103.15 | 98.02 | -4.97% | Details |
| 5/2/2013 | Lazard Capital | Upgrade | Buy (Hold) |
N/A (N/A) |
98.67 | 98.02 | -0.66% | Details |
| 5/1/2013 | Morgan Stanley | Downgrade | Equalweight (Overweight) |
N/A (N/A) |
113.55 | 98.02 | -13.68% | Details |
| 3/7/2013 | Buckingham Research | Downgrade | Neutral (Buy) |
120.00 (N/A) |
111.47 | 98.02 | -12.07% | Details |
| 2/6/2013 | JMP Securities | Upgrade | Market Outperform (Market Perform) |
135.00 (N/A) |
106.70 | 98.02 | -8.13% | Details |
| 11/30/2012 | Citi | New Coverage | Buy (N/A) |
106.00 (N/A) |
92.33 | 98.02 | 6.16% | Details |
| 11/16/2012 | SunTrust Robinson Humphrey | New Coverage | Buy (N/A) |
103.00 (N/A) |
89.17 | 98.02 | 9.92% | Details |
| 9/24/2012 | CLSA | Upgrade | Outperform (Underperform) |
103.00 (98.00) |
91.50 | 98.02 | 7.13% | Details |
| 9/19/2012 | Canaccord Genuity » Updated 1/22/2013 |
New Coverage | Hold (N/A) |
102.00 (101.00) |
89.84 | 98.02 | 9.11% | Details |
| 9/18/2012 | Guggenheim | New Coverage | Buy (N/A) |
102.00 (N/A) |
88.85 | 98.02 | 10.32% | Details |
| 8/27/2012 | William Blair | New Coverage | Outperform (N/A) |
N/A (N/A) |
85.25 | 98.02 | 14.98% | Details |
| 12/9/2011 | Barclays » Updated 3/29/2012 |
New Coverage | Equalweight (N/A) |
95.00 (N/A) |
81.95 | 98.02 | 19.61% | Details |
| 12/1/2011 | Argus | Upgrade | Buy (N/A) |
N/A (N/A) |
83.72 | 98.02 | 17.08% | Details |
| 9/16/2011 | Deutsche Bank » Updated 2/6/2013 |
New Coverage | Buy (N/A) |
113.00 (108.00) |
82.35 | 98.02 | 19.03% | Details |
| 8/16/2011 | Credit Suisse » Updated 3/29/2012 |
Upgrade | Outperform (N/A) |
104.00 (N/A) |
74.75 | 98.02 | 31.13% | Details |
